Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/19/2009 | US20090286885 Ethylene-tetrafluoroethylene phosphate composition |
11/19/2009 | US20090286867 Compositions and methods of administering doxepin to mucosal tissue |
11/19/2009 | US20090286743 Methods and Compositions for Treating Conditions of the Eye |
11/19/2009 | US20090286737 Erbb interface peptidomimetics and methods of use thereof |
11/19/2009 | US20090286735 Method for administering glp-1 molecules |
11/19/2009 | US20090286732 Compounds for delivery of therapeutic and imaging moieties to nerve cells |
11/19/2009 | US20090286715 Pharmaceutical Composition |
11/19/2009 | US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
11/19/2009 | US20090285897 Rehydratable thiolated polysaccharide particles and sponge |
11/19/2009 | US20090285895 Pharmaceutical Formulation for Regulating the Timed Release of Biologically Active Compounds Based on a Polymer Matrix |
11/19/2009 | US20090285885 Method of forming a drug nanocarrier having a magnetic shell |
11/19/2009 | US20090285863 Coating Composition Comprising Starch |
11/19/2009 | US20090285833 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading |
11/19/2009 | US20090285822 Prevention and treatment of amyloidogenic disease |
11/19/2009 | US20090285816 Albumin Fusion Proteins |
11/19/2009 | US20090285809 Prevention and treatment of amyloidogenic diseases |
11/19/2009 | US20090285802 Highly concentrated stabilized igm solution |
11/19/2009 | US20090285780 Peg linker compounds and biologically active conjugates thereof |
11/19/2009 | US20090285778 Use of interleukin-19 to treat cervical cancer |
11/19/2009 | US20090285771 Methods and compositions for needleless delivery of macromolecules |
11/19/2009 | US20090285769 Oxathiane derivative as perfuming ingredient |
11/19/2009 | US20090285755 Methods for tumor diagnosis and therapy |
11/19/2009 | US20090285753 Novel haptotactic peptides |
11/19/2009 | CA2724630A1 Targeted coagulation factors and method of using the same |
11/19/2009 | CA2724472A1 Micelles for intracellular delivery of therapeutic agents |
11/19/2009 | CA2724455A1 Polymeric carrier |
11/19/2009 | CA2724384A1 Treatment of metastatic tumors |
11/19/2009 | CA2724178A1 Polymer microgel beads |
11/19/2009 | CA2724177A1 Polymer microgel beads and preparative method thereof |
11/19/2009 | CA2723821A1 Conjugates of a cholinesterase moiety and a polymer |
11/19/2009 | CA2723458A1 Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
11/19/2009 | CA2722602A1 Stable pharmaceutical formulations |
11/19/2009 | CA2721961A1 Silk polymer-based adenosine release: therapeutic potential for epilepsy |
11/18/2009 | EP2119785A1 Novel peptides |
11/18/2009 | EP2119738A1 Polyethylene glycol derivative |
11/18/2009 | EP2119458A1 Method for production of radiation diagnostic imaging agent |
11/18/2009 | EP2119455A1 Tripartite raftophilic structures and their use |
11/18/2009 | EP2119454A1 Pharmaceutical composition comprising porous dry matrix |
11/18/2009 | EP2119451A1 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
11/18/2009 | EP2119449A1 Hgf preparation |
11/18/2009 | EP2119446A1 Epithelium improving agent |
11/18/2009 | EP2119442A1 Tacrolimus sustained release pharmaceutical composition |
11/18/2009 | EP2119438A1 Bone metabolism ameliorating agent |
11/18/2009 | EP2119437A1 Device for the transdermal administration of bisoprolol |
11/18/2009 | EP2118145A2 Modified saccharides |
11/18/2009 | EP2118131A1 Glucagon-like protein-1 receptor (glp-1r) agonist compounds |
11/18/2009 | EP2118127A2 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
11/18/2009 | EP2117600A2 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |
11/18/2009 | EP2117599A1 Membrane(s) and uses thereof |
11/18/2009 | EP2117598A2 Formulations of deacetylase inhibitors |
11/18/2009 | EP2117597A1 Oil-in-oil emulsion-type pharmaceutical composition |
11/18/2009 | EP2117595A2 Remotely triggered release from heatable surfaces |
11/18/2009 | EP2117593A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
11/18/2009 | EP2117563A1 Amidinoanthracycline antibiotics for use in the treatment of viral infections |
11/18/2009 | EP2117528A2 Use of adenosine deaminase for treating pulmonary disease |
11/18/2009 | EP2117520A1 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
11/18/2009 | EP2117514A1 Compositions comprising peg- interferon alpha conjugates and raffinose as cryoprotectant |
11/18/2009 | EP2117507A2 Compositions for aerosolization of highly conductive solutions |
11/18/2009 | EP2117503A1 A controlled release composition comprising a recombinant gelatin |
11/18/2009 | EP2117502A2 Composition for combating epistaxis |
11/18/2009 | EP2117500A1 Dermal film-forming liquid formulations for drug release to skin |
11/18/2009 | EP1973570B1 Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kda and processes for their preparation |
11/18/2009 | EP1771498B1 Branched polyaminoacids, functionalized by hydrophobic groups and uses thereof in particular in therapy |
11/18/2009 | EP1545453B1 Rifalazil for treating infections of clostridium difficile |
11/18/2009 | EP1501551B1 Folate-receptor targeted imaging agents |
11/18/2009 | EP1463541B1 Biomaterials based on hyaluronic acid benzyl ester for the anti-angiogenic therapy in the treatment of tumours |
11/18/2009 | EP0957901B1 Pharmaceutical preparations of glutathione and methods of administration thereof |
11/18/2009 | EP0904112B1 Composition comprising il-1ra as interleukin-1 inhibitor and hyaluronan as controlled release polymer |
11/18/2009 | CN101583629A Modified saccharides |
11/18/2009 | CN101583625A Anti-CD16 binding molecules |
11/18/2009 | CN101583380A Method for preparing a polymer conjugate |
11/18/2009 | CN101583379A Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles |
11/18/2009 | CN101583378A Anti-microorganism terpenic composition |
11/18/2009 | CN101583373A Therapeutic agent for interstitial pneumonia |
11/18/2009 | CN101583366A Radiation sensitizer or anti-cancer chemotherapy sensitizer |
11/18/2009 | CN101583339A Compositions comprising macromolecular assemblies of lipid and surfactant |
11/18/2009 | CN101580547A HASylated polypeptides, especially HASylated erythropoietin |
11/18/2009 | CN101580524A Method for preparing digalactosyldiacylglycerol and application thereof |
11/18/2009 | CN101580239A Glycosyl biforate carbon material and preparation method and application thereof |
11/18/2009 | CN101579526A Epsilon-caprolactone polymer featuring key joint by folic acid |
11/18/2009 | CN101579525A Disintegrating agent as well as manufacturing method and application method thereof |
11/18/2009 | CN101579524A Taste-masking coated composition, coated liquid and formulation |
11/18/2009 | CN101579523A Egg yolk immunoglobulins oral and throat spraying agent and preparation method thereof |
11/18/2009 | CN101579506A Bezoar chest functioning preparation and preparation method thereof |
11/18/2009 | CN101579505A Restorative preparation and preparation method thereof |
11/18/2009 | CN101579502A Wormwood strip containing natural aromatic plants |
11/18/2009 | CN101579500A Gynaecologic restorative pharmaceutic preparation and preparation technology and quality control method thereof |
11/18/2009 | CN101579498A Ready-to-use zedoary turmeric oil ophthalmic gel |
11/18/2009 | CN101579480A Medicinal dripping pill for treating hypertension |
11/18/2009 | CN101579469A Medicament for curing chronic appendicitis and preparation method thereof |
11/18/2009 | CN101579449A Method for preparing oleum viticis negundo dripping pills |
11/18/2009 | CN101579440A Traditional Chinese medicine preparation used for thrombocytopenia and leukopenia |
11/18/2009 | CN101579437A Medicinal dripping pill for treating adiposity |
11/18/2009 | CN101579431A Ready-to-use herba houttuyniae ophthalmic gel |
11/18/2009 | CN101579428A Zhuhuang Chuihou preparation and preparation technology thereof |
11/18/2009 | CN101579425A Oral pharmaceutical preparation |
11/18/2009 | CN101579415A Medicinal dripping pill for treating biliary calculus |
11/18/2009 | CN101579411A Medicinal dripping pill for treating prostatauxe |
11/18/2009 | CN101579403A Ready-to-use Dactylicapnos scandens ophthalmic gel |
11/18/2009 | CN101579402A Ready-to-use decumbent corydalis tuber ophthalmic gel |